Study: Statins Can Improve Survival in Renal Cell Carcinoma

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers found that patients being treated with statins at the time of surgery for renal cell carcinoma had improved overall survival and disease-specific survival.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Login